Collections in this community

Recent Submissions

1. Access to antiviral therapy for chronic hepatitis B during COVID-19

   REVISTA DA ASSOCIAçãO MéDICA BRASILEIRA, v.68, n.11, p.1509-1513, 2022

   Abstract OBJECTIVE: Hepatitis B is an important public health concern. Currently, the COVID-19 pandemic is a major challenge for health systems, and the access to pharmacologic and non-pharmacologic treatment of chronic diseases, such as hepatitis B, may have been affected due to the contingency ...

2. BRAZILIAN SOCIETY OF HEPATOLOGY UPDATED RECOMMENDATIONS FOR SYSTEMIC TREATMENT OF HEPATOCELLULAR CARCINOMA

   ARQUIVOS DE GASTROENTEROLOGIA, v.60, n.1, p.106-131, 2023

   ABSTRACT Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. The Brazilian Society of Hepatology (SBH) published in 2020 the updated recommendations for the diagnosis and treatment of HCC. Since then, new data have emerged in the literature, includ...

3. PNPLA3 GENE POLYMORPHISM AND RED MEAT CONSUMPTION INCREASED FIBROSIS RISK IN NASH BIOPSY-PROVEN PATIENTS UNDER MEDICAL FOLLOW-UP IN A TERTIARY CENTER IN SOUTHWEST BRAZIL

   ARQUIVOS DE GASTROENTEROLOGIA, v.60, n.1, p.98-105, 2023

   ABSTRACT Background: Recent studies show an increase in nonalcoholic fatty liver disease (NAFLD) in populations with higher consumption of red meat, processed and cooked at high temperatures. On the other hand, the single nucleotide polymorphism rs738409 in the Patatin-like phospholipase domain c...

4. High versus low mean arterial pressure target in liver transplant patients. An open, controlled, single-center, randomized clinical trial - Protocol and methods (LIVER-PAM)

   CRITICAL CARE SCIENCE, v.35, n.1, p.11-18, 2023

   ABSTRACT Objective: To explain the rationale and protocol of the methods and analyses to be used in the LIVER-PAM randomized clinical trial, which seeks to understand whether a higher mean arterial pressure is capable of reducing the incidence of renal dysfunction postoperatively after liver tran...

5. Apresentação

   Ribeiro Júnior, Ulysses; Kulcsar, Marco Aurelio Vamondes. Apresentação. In: Ribeiro Júnior, Ulysses; Kulcsar, Marco Aurelio Vamondes (eds). Manual de condutas em oncologia cirúrgica. SÃO PAULO: Atheneu, 2014. p.XLI-XLII.

6. Apresentação

   Marin, Márcia Lúcia de Mário; Maluvayshi, Cleide Harue; Waitzberg, Dan Linetzky. Apresentação. In: Marin, Márcia Lúcia de Mário; Maluvayshi, Cleide Harue; Waitzberg, Dan Linetzky (coords). Manual de interações fármaco-alimento: nutriente na prática clínica. RIO DE JANEIRO: Atheneu, 2018. p.XI-XII.

7. Manual de interações fármaco-alimento: nutriente na prática clínica

   . Manual de interações fármaco-alimento: nutriente na prática clínica. RIO DE JANEIRO: Atheneu, 2018. 87p.

8. Quadros e portais úteis

   Faintuch, Joel; Faintuch, Jacob Jehuda; Mishaly, Asher. Quadros e portais úteis. In: Faintuch, Joel (ed). Manual do residente de cirurgia. SANTANA DE PARNAÍBA: Manole, 2023. p.509-514.

9. Transplante fecal no tratamento de obesidade, intolerância à glicose e outros quadros de dismetabolismo

   Faintuch, Joel; Faintuch, Jacob Jehuda; Mishaly, Asher. Transplante fecal no tratamento de obesidade, intolerância à glicose e outros quadros de dismetabolismo. In: Faintuch, Joel (ed). Manual do residente de cirurgia. SANTANA DE PARNAÍBA: Manole, 2023. p.295-303.

10. A reengenharia do microbioma como plataforma farmacológica do futuro

    Faintuch, Joel. A reengenharia do microbioma como plataforma farmacológica do futuro. In: Faintuch, Joel (ed). Microbioma, disbiose, probióticos e bacterioterapia. BARUERI: Manole, 2017. p.316-321.